FDA advisers to weigh risks of Abbott’s dissolving stent

(Reuters) - U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted.

http://ift.tt/1pHzJYm

from Reuters: Health News
via animenewspro